Fascinating Facts about the Arthritis Foundation Research Program

 

Our Research Program is Impactful

 Since 1948, the Arthritis Foundation has funded more than $470 million in research grants and we will  continue to mobilize public and private funding for research that guides and accelerates progress toward the prevention and cure of osteoarthritis, rheumatoid arthritis and juvenile arthritis. Representing the more than 50 million Americans suffering from arthritis, we bring together researchers, clinicians, policymakers, patient groups and industry partners around shared research goals and strategies that will result in major benefits for people with arthritis.

 Historical Data Since Inception (1948-2013)

Number of  Funded Researchers

2665

Number of  Funded Institutions

247

Number of  Training Grants

> 2000 

Invested Amount

$472,572,923

 

 

 

 

  

 2013

Number of  Active Research Grants

129

Number of  Active Training Grants

95

Number of  Currently Funded Institutions

68 

Number of Grant Applications Received

205

 

 

 

  

 

  

  • 2,665 researchers funded since 1948
  • $472,572,923 invested in arthritis research since 1948
  • 205 research grant applications received in 2013
  • 150 peer reviewers each year
  • 2000 hours volunteered by our peer reviewers each year
  • 10-year partnership with CARRA (Childhood Arthritis & Rheumatology Research Alliance)
  • $3,121,224 supporting juvenile arthritis research through CARRA partnership
  • Partners to achieve our research goals: Foundation for National Institutes of Health (FNIH), OA Research Society International (OARSI), Childhood Arthritis & Rheumatology Research Alliance (CARRA), American Orthopaedic Society for Sports Medicine (AOSSM), AOII Foundation, Orthopedic Research Society (ORS)
  • 137 attendees at the AF’s 2012 Segal North American Osteoarthritis Workshop (SNOW) meeting, representing 8 countries and 35 institutions
  • Using his AF research grant in the early 1980s, Dr. Bill Arend studied the role of IL-1 in RA – work that led to the development of Kineret, one of the biologics used to treat RA today
  • $4.7 Million allocated to arthritis research by the Department of Defense thanks to the AF’s advocacy efforts
  • $600,000 toward FNIH partnership on OA Biomarkers to drive toward a new treatment
  • $100,000 toward the public-private Accelerating Medicines Partnership RA/SLE Program

 

 

 

 

 

 

 

 

 

 

Nebo Content Management System Tracking